| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
0 | 0 | 0 | 30,000 | 5,160 | 26,137 | 18,564 | 12,987 | 11,449 | 1,512 |
Operating expenses: | |||||||||
Research and development | |||||||||
26,742 | 21,474 | 18,368 | 18,718 | 15,523 | 13,678 | 9,200 | 8,894 | 8,761 | 6,061 |
General and administrative | |||||||||
7,369 | 5,136 | 4,965 | 5,233 | 4,508 | 4,197 | 2,887 | 2,222 | 2,156 | 1,329 |
Total operating expenses | |||||||||
34,111 | 26,610 | 23,333 | 23,951 | 20,031 | 17,875 | 12,087 | 11,116 | 10,917 | 7,390 |
Loss from operations | |||||||||
-34,111 | -26,610 | -23,333 | 6,049 | -14,871 | 8,262 | 6,477 | 1,871 | 532 | -5,878 |
Other income, net | |||||||||
0 | 38 | 3 | -42 | 1 | 3 | -133 | -186 | -337 | 274 |
Interest income | |||||||||
1,612 | 1,648 | 1,034 | 1,108 | 1,183 | 1,112 | 339 | 112 | 115 | - |
Net loss | |||||||||
-32,499 | -24,924 | -22,296 | 7,115 | -13,687 | 9,377 | 6,683 | 1,797 | 310 | -7,125 |
Net loss per share, basic and diluted | |||||||||
-0.99 | - | - | - | -0.57 | - | - | - | - | - |
Weighted-average shares used to calculate net loss per share, basic and diluted | |||||||||
32,993 | - | - | - | 23,866 | - | - | - | - | - |
Interest expense | |||||||||
- | - | - | - | - | - | - | - | - | -1,521 |
Net income (loss) attributable to common stockholders | |||||||||
- | - | -22,296 | 7,115 | - | 4,917 | 0 | 0 | 0 | - |
Net income (loss) per share attributable to common stockholders | |||||||||
Basic | |||||||||
- | - | -0.93 | 0.30 | - | 0.65 | 0.00 | 0.00 | 0.00 | -12.26 |
Diluted | |||||||||
- | - | -0.93 | 0.28 | - | 0.57 | 0.00 | 0.00 | 0.00 | -12.26 |
Weighted-average shares used to calculate net income (loss) per share attributable to common stockholders | |||||||||
Basic | |||||||||
- | - | 24,018 | 23,927 | - | 24,090 | 5,087 | 681 | 630 | 581 |
Diluted | |||||||||
- | - | 24,018 | 25,792 | - | 25,781 | 6,144 | 1,412 | 1,170 | 581 |